Cet essai de phase 2 évalue trois candidats-vaccins : Candidat-vaccin combiné COVID-Influenza, candidat-vaccin autonome contre la grippe et candidat-vaccin à forte dose contre la COVID-19 Les...
TOKYO, May 11, 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (hereinafter “NX Italia”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired IATA CEIV Pharma certification*, a quality...
TOKYO, May 11, 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (hereinafter “NX Italia”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired IATA CEIV Pharma certification*, a quality...